STOCK TITAN

[8-K] InspireMD, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

InspireMD, Inc. filed an 8-K dated August 5, 2025 reporting that it issued a press release with financial and operating results for the three and six months ended June 30, 2025 (Item 2.02) and made an updated investor presentation available (Item 7.01).

The filing states the press release is attached as Exhibit 99.1 and the investor presentation as Exhibit 99.2, and that both are furnished (not "filed") under General Instruction B.2. The presentation is available on the company website at https://www.inspiremd.com/en/investors/. This 8-K does not include the underlying financial figures; readers must consult the attached exhibits for results.

InspireMD, Inc. ha depositato un 8-K datato 5 agosto 2025 segnalando di aver diffuso un comunicato stampa con i risultati finanziari e operativi per i tre e sei mesi conclusi il 30 giugno 2025 (Item 2.02) e di aver reso disponibile una presentazione aggiornata per gli investitori (Item 7.01).

La relazione indica che il comunicato stampa è allegato come Exhibit 99.1 e la presentazione come Exhibit 99.2, e che entrambi sono forniti (non 'depositati'). La presentazione è disponibile sul sito della società all'indirizzo https://www.inspiremd.com/en/investors/. Questo 8-K non include le cifre finanziarie sottostanti; i lettori devono consultare gli exhibit allegati per i risultati.

InspireMD, Inc. presentó un 8-K fechado el 5 de agosto de 2025 informando que emitió un comunicado de prensa con los resultados financieros y operativos correspondientes a los tres y seis meses terminados el 30 de junio de 2025 (Item 2.02) y que puso a disposición una presentación actualizada para inversores (Item 7.01).

La presentación indica que el comunicado está adjunto como Exhibit 99.1 y la presentación como Exhibit 99.2, y que ambos se han proporcionado (no 'presentados'). La presentación está disponible en la web de la compañía en https://www.inspiremd.com/en/investors/. Este 8-K no incluye las cifras financieras subyacentes; los lectores deben consultar los anexos adjuntos para conocer los resultados.

InspireMD, Inc.2025년 8월 5일2025년 6월 30일 종료된 3개월 및 6개월의 재무 및 운영 실적에 관한 보도자료를 발표(항목 2.02)하고 투자자용 업데이트 프레젠테이션을 게시(항목 7.01)했다고 보고했습니다.

해당 제출서류에는 보도자료가 Exhibit 99.1로, 프레젠테이션이 Exhibit 99.2로 첨부되어 있으며, 둘 다 제출('filed')된 것이 아니라 제공('furnished')된 것으로 명시되어 있습니다. 프레젠테이션은 회사 웹사이트 https://www.inspiremd.com/en/investors/에서 확인할 수 있습니다. 이 8-K에는 기초 재무 수치가 포함되어 있지 않으므로 결과는 첨부된 exhibits를 참조해야 합니다.

InspireMD, Inc. a déposé un 8-K daté du 5 août 2025 indiquant qu'elle avait publié un communiqué de presse présentant les résultats financiers et opérationnels pour les trois et six mois clos le 30 juin 2025 (Item 2.02) et qu'elle avait rendu disponible une présentation investisseurs mise à jour (Item 7.01).

Le dépôt précise que le communiqué est joint en tant que Exhibit 99.1 et la présentation en tant que Exhibit 99.2, et que les deux sont fournis (et non 'filed'). La présentation est accessible sur le site de la société à l'adresse https://www.inspiremd.com/en/investors/. Ce 8-K n'inclut pas les chiffres financiers sous-jacents ; les lecteurs doivent consulter les exhibits joints pour connaître les résultats.

InspireMD, Inc. reichte ein 8-K mit Datum 5. August 2025 ein und berichtete, dass eine Pressemitteilung mit den Finanz‑ und Betriebsergebnissen für die drei bzw. sechs Monate zum 30. Juni 2025 veröffentlicht wurde (Item 2.02) und eine aktualisierte Investorenpräsentation bereitgestellt wurde (Item 7.01).

In der Einreichung heißt es, die Pressemitteilung sei als Exhibit 99.1 und die Präsentation als Exhibit 99.2 beigefügt, und beide seien bereitgestellt (nicht 'filed'). Die Präsentation ist auf der Unternehmenswebsite unter https://www.inspiremd.com/en/investors/ verfügbar. Dieses 8-K enthält keine zugrunde liegenden Finanzzahlen; die Leser müssen die beigefügten Exhibits für die Ergebnisse einsehen.

Positive
  • Timely disclosure of press release and updated investor presentation on August 5, 2025
  • Exhibits attached (Exhibit 99.1 press release; Exhibit 99.2 investor presentation) for investor review
  • Presentation available on the company investor website for direct access
Negative
  • No financial figures or operating metrics are included in the 8-K body; details require consulting Exhibit 99.1
  • Information furnished, not filed, which limits Section 18 liability and may affect incorporation by reference into other filings

Insights

TL;DR: Routine 8-K furnishing results press release and updated deck; no figures included here, review exhibits for material detail.

The filing serves primarily to notify investors that a press release on Q2 and six-month results and an updated investor presentation were furnished on August 5, 2025. As the 8-K itself contains no financial metrics, its direct informational value is limited until Exhibit 99.1 is reviewed. The "furnished, not filed" status preserves Section 18 liability limitations; analysts should retrieve the press release and deck for quantitative assessment.

TL;DR: Disclosure is procedurally appropriate and timely, but material content resides in exhibits rather than the 8-K body.

The report follows standard practice by furnishing an earnings-related press release and an investor presentation and by citing General Instruction B.2 to limit Section 18 liability. From a governance and compliance perspective, the company met disclosure obligations. Investors should note the distinction between "furnished" and "filed" when considering incorporation by reference into future registration statements.

InspireMD, Inc. ha depositato un 8-K datato 5 agosto 2025 segnalando di aver diffuso un comunicato stampa con i risultati finanziari e operativi per i tre e sei mesi conclusi il 30 giugno 2025 (Item 2.02) e di aver reso disponibile una presentazione aggiornata per gli investitori (Item 7.01).

La relazione indica che il comunicato stampa è allegato come Exhibit 99.1 e la presentazione come Exhibit 99.2, e che entrambi sono forniti (non 'depositati'). La presentazione è disponibile sul sito della società all'indirizzo https://www.inspiremd.com/en/investors/. Questo 8-K non include le cifre finanziarie sottostanti; i lettori devono consultare gli exhibit allegati per i risultati.

InspireMD, Inc. presentó un 8-K fechado el 5 de agosto de 2025 informando que emitió un comunicado de prensa con los resultados financieros y operativos correspondientes a los tres y seis meses terminados el 30 de junio de 2025 (Item 2.02) y que puso a disposición una presentación actualizada para inversores (Item 7.01).

La presentación indica que el comunicado está adjunto como Exhibit 99.1 y la presentación como Exhibit 99.2, y que ambos se han proporcionado (no 'presentados'). La presentación está disponible en la web de la compañía en https://www.inspiremd.com/en/investors/. Este 8-K no incluye las cifras financieras subyacentes; los lectores deben consultar los anexos adjuntos para conocer los resultados.

InspireMD, Inc.2025년 8월 5일2025년 6월 30일 종료된 3개월 및 6개월의 재무 및 운영 실적에 관한 보도자료를 발표(항목 2.02)하고 투자자용 업데이트 프레젠테이션을 게시(항목 7.01)했다고 보고했습니다.

해당 제출서류에는 보도자료가 Exhibit 99.1로, 프레젠테이션이 Exhibit 99.2로 첨부되어 있으며, 둘 다 제출('filed')된 것이 아니라 제공('furnished')된 것으로 명시되어 있습니다. 프레젠테이션은 회사 웹사이트 https://www.inspiremd.com/en/investors/에서 확인할 수 있습니다. 이 8-K에는 기초 재무 수치가 포함되어 있지 않으므로 결과는 첨부된 exhibits를 참조해야 합니다.

InspireMD, Inc. a déposé un 8-K daté du 5 août 2025 indiquant qu'elle avait publié un communiqué de presse présentant les résultats financiers et opérationnels pour les trois et six mois clos le 30 juin 2025 (Item 2.02) et qu'elle avait rendu disponible une présentation investisseurs mise à jour (Item 7.01).

Le dépôt précise que le communiqué est joint en tant que Exhibit 99.1 et la présentation en tant que Exhibit 99.2, et que les deux sont fournis (et non 'filed'). La présentation est accessible sur le site de la société à l'adresse https://www.inspiremd.com/en/investors/. Ce 8-K n'inclut pas les chiffres financiers sous-jacents ; les lecteurs doivent consulter les exhibits joints pour connaître les résultats.

InspireMD, Inc. reichte ein 8-K mit Datum 5. August 2025 ein und berichtete, dass eine Pressemitteilung mit den Finanz‑ und Betriebsergebnissen für die drei bzw. sechs Monate zum 30. Juni 2025 veröffentlicht wurde (Item 2.02) und eine aktualisierte Investorenpräsentation bereitgestellt wurde (Item 7.01).

In der Einreichung heißt es, die Pressemitteilung sei als Exhibit 99.1 und die Präsentation als Exhibit 99.2 beigefügt, und beide seien bereitgestellt (nicht 'filed'). Die Präsentation ist auf der Unternehmenswebsite unter https://www.inspiremd.com/en/investors/ verfügbar. Dieses 8-K enthält keine zugrunde liegenden Finanzzahlen; die Leser müssen die beigefügten Exhibits für die Ergebnisse einsehen.

false 0001433607 0001433607 2025-08-05 2025-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): August 5, 2025

 

InspireMD, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-35731   26-2123838

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

6303 Waterford District DriveSuite 215

MiamiFlorida

  33126
(Address of Principal Executive Offices)   (Zip Code)

 

(888) 776-6804

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   NSPR   The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition

 

On August 5, 2025, InspireMD, Inc. (the “Company”) issued a press release announcing its financial and operating results and recent highlights for the three and six months ended June 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this Item 2.02 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 7.01 Regulation FD Disclosure.

 

On August 5, 2025, the Company made available an updated investor presentation. A copy of the presentation is attached hereto as Exhibit 99.2 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on the Company’s website https://www.inspiremd.com/en/investors/.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this Item 7.01 shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number   Description
99.1   Press release, dated August 5, 2025 (furnished herewith pursuant to Item 2.02)
99.2   Investor Presentation August 2025 (furnished herewith pursuant to Item 7.01)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INSPIREMD, INC.
     
Date: August 5, 2025 By: /s/ Michael Lawless
  Name:  Michael Lawless
  Title: Chief Financial Officer

 

 

 

FAQ

When did InspireMD (NSPR) file this 8-K?

The 8-K was filed on August 5, 2025.

What does Item 2.02 disclose in this 8-K for NSPR?

Item 2.02 states the company issued a press release announcing financial and operating results for the three and six months ended June 30, 2025, attached as Exhibit 99.1.

Is there an investor presentation included with the filing?

Yes. An updated investor presentation is furnished as Exhibit 99.2 and is available on the company website at https://www.inspiremd.com/en/investors/.

Does the 8-K itself provide the financial results for Q2 2025?

No. The 8-K references a press release with results but does not include the financial figures in the 8-K text; consult Exhibit 99.1.

What is the significance of the disclosure being "furnished" and not "filed"?

The filing cites General Instruction B.2, meaning the furnished materials are not subject to Section 18 liability and are not automatically incorporated by reference into other registration statements.
Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

100.13M
30.13M
22.45%
40.55%
0.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI